Partnering with leading pharma and biotech companies.

Scroll to explore more

Trusted by

Highlights

WeWe getget results.results.

WeWe getget results.results.

WeWe getget results.results.

Antibodies designed by Antiverse are close to the clinic.

Antiverse generated lead candidates with therapeutic development potential that have functional profiles better than Keytruda. Our antibodies are currently in IND-enabling.

Antibodies designed by Antiverse are close to the clinic.

Antiverse generated lead candidates with therapeutic development potential that have functional profiles better than Keytruda. Our antibodies are currently in IND-enabling.

Antiverse designed functional, optimized agonist antibodies 
in 4 months.

We designed functional agonist antibodies for a Class A GPCR target previously considered intractable for biologics.

Antiverse designed functional, optimized agonist antibodies 
in 4 months.

We designed functional agonist antibodies for a Class A GPCR target previously considered intractable for biologics.

Read the latest

Timeline

From GPCR target to functional leads in just 4 months.

Month 1

Month 2

Month 3

Month 4

Example timeline, as executed by Antiverse.

1

Epitope-specificEpitope-specific designdesign

Epitope-specificEpitope-specific designdesign

Epitope-specificEpitope-specific designdesign

Target assessment, epitope strategy, generative library design.

2

DeDe novonovo generationgeneration

DeDe novonovo generationgeneration

DeDe novonovo generationgeneration

De novo libraries synthesised while high-density cell lines are being developed.

3

Wet-labWet-lab ScreeningScreening

Wet-labWet-lab ScreeningScreening

Wet-labWet-lab ScreeningScreening

Binder selection in proprietary cell lines.

4

OptimisedOptimised antibodiesantibodies

OptimisedOptimised antibodiesantibodies

OptimisedOptimised antibodiesantibodies

Functional lead antibodies with optimised developability profiles.

Let'sLet's buildbuild thethe futurefuture ofof biologicsbiologics together.together.

Let'sLet's buildbuild thethe futurefuture ofof biologicsbiologics together.together.

Let'sLet's buildbuild thethe futurefuture ofof biologicsbiologics together.together.

Partner with us

Our flexible business model enables us to drive strategic innovation.

Contact us

Our Science

Platform

Pipeline

Partnerships

Contact